Summary of Study ST003191
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001987. The data can be accessed directly via it's Project DOI: 10.21228/M8WB25 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003191 |
Study Title | Fructose 1,6-bisphosphate quantification in HepG2 liver cancer cell line. |
Study Type | LC/MS Quantitative Analysis |
Study Summary | Quantification of specific fructose 1,6-bisphosphate (FBP) concentrations in HepG2 cells. A minimum of 1 million cells per replicate and condition will be grown and treated. Glucose-starved cells will be either treated with 10 mM glucose, 2.5 μM Oligomycin, 50 mM 2-deoxy-D-glucose (2-DG), or not treated. Cells will be lysed and processed for FBP quantification using an isotope FBP standard by LC/MS. |
Institute | Vrije Universiteit Brussel |
Department | VIB-VUB Center for Structural Biology |
Laboratory | RedOx Laboratory |
Last Name | Perez Chavez |
First Name | Israel |
Address | Pleinlaan 2, building E, 4th floor |
israel.perez.chavez@vub.be | |
Phone | +32 474160756 |
Submit Date | 2024-05-04 |
Raw Data Available | Yes |
Raw Data File Type(s) | mzML |
Analysis Type Detail | LC-MS |
Release Date | 2024-08-05 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001987 |
Project DOI: | doi: 10.21228/M8WB25 |
Project Title: | Fructose 1,6-bisphosphate quantification in HepG2 liver cancer cell line |
Project Type: | LC/MS Quantitative Analysis |
Project Summary: | Quantification of specific fructose 1,6-bisphosphate (FBP) concentrations in HepG2 cells. A minimum of 1 million cells per replicate and condition will be grown and treated. Glucose-starved cells will be either treated with 10 mM glucose, 2.5 μM Oligomycin, 50 mM 2-deoxy-D-glucose (2-DG), or not treated. Cells will be lysed and processed for FBP quantification using an isotope FBP standard by LC/MS. |
Institute: | Vrije Universiteit Brussel |
Department: | VIB-VUB Center for Structural Biology |
Laboratory: | RedOx Laboratory |
Last Name: | Perez Chavez |
First Name: | Israel |
Address: | Boulevard de la Plaine 2 |
Email: | israel.perez.chavez@vub.be |
Phone: | +32 474160756 |
Subject:
Subject ID: | SU003310 |
Subject Type: | Cultured cells |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Gender: | Male |
Cell Strain Details: | HepG2 Cells |
Factors:
Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample source | Treatment |
---|---|---|---|
SA347888 | MCF001881_IP04 | Liver Cancer Cell Line | 10 mM Glucose |
SA347889 | MCF001881_IP06 | Liver Cancer Cell Line | 10 mM Glucose |
SA347890 | MCF001881_IP05 | Liver Cancer Cell Line | 10 mM Glucose |
SA347891 | MCF001881_IP09 | Liver Cancer Cell Line | 2.5 µM Oligomycin |
SA347892 | MCF001881_IP08 | Liver Cancer Cell Line | 2.5 µM Oligomycin |
SA347893 | MCF001881_IP07 | Liver Cancer Cell Line | 2.5 µM Oligomycin |
SA347894 | MCF001881_IP12 | Liver Cancer Cell Line | 50 mM 2-Deoxy-D-Glucose |
SA347895 | MCF001881_IP11 | Liver Cancer Cell Line | 50 mM 2-Deoxy-D-Glucose |
SA347896 | MCF001881_IP10 | Liver Cancer Cell Line | 50 mM 2-Deoxy-D-Glucose |
SA347897 | MCF001881_IP02 | Liver Cancer Cell Line | Control |
SA347898 | MCF001881_IP03 | Liver Cancer Cell Line | Control |
SA347899 | MCF001881_IP01 | Liver Cancer Cell Line | Control |
Showing results 1 to 12 of 12 |
Collection:
Collection ID: | CO003303 |
Collection Summary: | Cells were trypsinized, washed, counted, centrifuged, resuspended in extraction buffer, centrifuged, and the supernatant stored at -80°C. |
Collection Protocol Filename: | FBPquantificationMethod.pdf |
Sample Type: | HepG2 cells |
Treatment:
Treatment ID: | TR003319 |
Treatment Summary: | Cells were glucose starved for 1 h. Then, it involved the addition of 10 mM glucose, 2.5 μM of oligomycin, and 50 mM of 2-DG. |
Sample Preparation:
Sampleprep ID: | SP003317 |
Sampleprep Summary: | The cell pellet was resuspended in 100 µL of extraction buffer (80% Methanol/20% mQ water + 2 µM Fructose-1,6-bisphosphate (U-¹³C₆). Cells were then incubated for 3 min on ice and then spun at 20.000 x g 4°C for 20 min. The supernatant was collected and stored at -80°C until metabolomics analysis. This procedure was performed in control, after glucose addition, oligomycin and 2-DG addition. |
Combined analysis:
Analysis ID | AN005239 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Thermo Dionex Ultimate 3000 |
Column | Waters ACQUITY UPLC HSS T3 (150 x 2.1mm,1.8um) |
MS Type | ESI |
MS instrument type | Orbitrap |
MS instrument name | Thermo Q Exactive Orbitrap |
Ion Mode | NEGATIVE |
Units | µM |
Chromatography:
Chromatography ID: | CH003966 |
Instrument Name: | Thermo Dionex Ultimate 3000 |
Column Name: | Waters ACQUITY UPLC HSS T3 (150 x 2.1mm,1.8um) |
Column Temperature: | 40℃ |
Flow Gradient: | 0-13 min: 0% B; 13-14 min: 33.33% B; 14-25 min: 36.4% B |
Flow Rate: | 0.25 mL/min |
Solvent A: | 95% milliQ Water, 5% Methanol; 10 mM Tertiary Butyl Alcohol and 15 mM acetic acid |
Solvent B: | 100% methanol |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS004972 |
Analysis ID: | AN005239 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | The mass spectrometer operated in full scan (range [70.0000-1050.0000]) and AGC target was set at 3.0E+006 using a resolution of 140000. Data collection was performed using the Xcalibur software (Thermo Scientific). The data analyses were performed by integrating the peak areas (El-Maven – Polly - Elucidata). |
Ion Mode: | NEGATIVE |